Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): are neurologists feeling more comfortable to RESTART antiplatelet?
Authors:
- 1 September 2019
- journal article
- editorial
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 7 (S6) , S214
Abstract
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): are neurologists feeling more comfortable to RESTART antiplatelet?Keywords
This publication has 20 references indexed in Scilit:
- Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trialThe Lancet Neurology, 2019
- Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trialThe Lancet, 2019
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart AssociationCirculation, 2019
- Stroke Epidemiology in South, East, and South-East Asia: A ReviewJournal of Stroke, 2017
- Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral HemorrhageStroke, 2016
- Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic AttackStroke, 2014
- Cerebral Amyloid Angiopathy in East and WestInternational Journal of Stroke, 2010
- Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathyNeurology, 2010
- The risk of recurrent stroke after intracerebral haemorrhageJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Antiplatelet use after intracerebral hemorrhageNeurology, 2006